Daily Briefing

What Changed

Choosing a hospitalisation-risk model for clinical deployment requires calibration evidence alongside discrimination [2].

Operations & Workflow | AI scribe documentation quality trails human clinicians, raising malpractice concerns. Human graders scored primary care notes from 11 commercial AI scribe tools significantly lower than notes from 18 clinicians on all 10 quality domains, with the largest gaps in thoroughness, organization, and usefulness [1].

Research & Evidence | LASSO was better calibrated than more complex models for hospitalisation-risk prediction. A preprint study using CPRD Aurum data evaluated Logistic Regression with LASSO, Random Forest, and TG-CNN models in elderly patients with multiple long-term conditions; after Platt calibration, only LASSO achieved an acceptable calibration slope (0.817), while Random Forest (0.759) and TG-CNN (0.391) remained substantially miscalibrated [2].

Medical Imaging | Future research should emphasize prospective multicenter evaluation. A paper reviewing 23 studies published in the Journal of Vascular Surgery found only 35% demonstrated meaningful external or prospective validation, calibration was unreported in 70% of studies, and performance varied across cohorts due to retrospective design, internal validation, and overfitting [3].

Research & Evidence | Maternal-health programs can adopt the XGBoost/LSTM pipeline to identify high-risk pregnancies in diverse populations. A preprint using the NIH All of Us Research Program constructed a longitudinal, multi-site, demographically diverse pregnancy dataset of 20,253 subjects and 27,525 episodes from EHR and survey data, then developed XGBoost and sequential LSTM models that achieved state-of-the-art performance for predicting seven maternal health adverse outcomes [4].